How does GHK-Cu pricing compare to other research peptides?

GHK-Cu is among the more accessible research peptides because the GHK tripeptide is small and the synthesis chemistry is well-characterized. Larger research peptides with complex modifications (like GLP-3 RT or GLP-2 TZ) are substantially more expensive. The relative pricing reflects the underlying synthesis complexity, not the research value of the molecule.

Are bulk and recurring purchase discounts available?

Yes. Many research peptide suppliers offer reduced per-unit pricing for bulk orders or recurring research lab purchases. Researchers running long-term studies that require consistent batch quality across multiple orders should inquire about volume pricing programs that maintain the same analytical specifications across larger orders.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Use code DAD15 at checkoutHappy Father's Day Sale: use code DAD15 at checkout

How Expensive Is GHK-Cu? (2026 Pricing Guide) | Midwest Peptide

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?Prev|Can You Buy GHK-Cu Over the Counter?Next

How Expensive Is GHK-Cu? (2026 Research Pricing Guide)

GHK-Cu · Published May 5, 2026 · 9 min read

Quick Answer

Research-grade GHK-Cu typically prices in the range of $30 to $80 for a 50mg lyophilized vial, depending on supplier, batch availability, and analytical depth. Suppliers that ship batch-specific Certificates of Analysis with HPLC purity, mass spectrometry identity, and ICP-MS copper quantification generally price above suppliers offering minimal documentation. The cheapest material is not always the most reproducible. For research use only, not for human consumption.

How Expensive Is GHK-Cu? (2026 Research Pricing Guide)

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

Typical 2026 Pricing for Research-Grade GHK-Cu
What Drives GHK-Cu Pricing
Why the Cheapest GHK-Cu Is Often a Yellow Flag
How GHK-Cu Pricing Compares Across the Catalog
Pricing for Research Designs That Use GHK-Cu Across Multiple Arms
How to Compare One Supplier's GHK-Cu Pricing Against Another's
What Midwest Peptide GHK-Cu Pricing Includes
External References for GHK-Cu Pricing Context
Bottom Line
Related Research Reading
Frequently Asked Questions
Glossary

Research-grade GHK-Cu pricing in 2026 reflects several interacting factors: the synthesis economics of a small tripeptide, the analytical depth that the supplier includes (HPLC, mass spec, ICP-MS), the batch volume the supplier is moving, and the supplier's overall quality positioning. This guide walks through what to expect from typical research-grade GHK-Cu pricing, what drives the price differences across suppliers, and how to evaluate price against the analytical documentation that determines research value.

Frequently Asked Questions

How much does GHK-Cu cost in 2026?

Research-grade GHK-Cu typically prices in the range of $30 to $80 for a 50mg lyophilized vial in 2026, depending on supplier, batch availability, and analytical depth. Suppliers offering full COA documentation including HPLC, mass spectrometry, and ICP-MS copper quantification generally price above suppliers offering minimal documentation.

What affects GHK-Cu pricing?

Five factors drive GHK-Cu pricing: (1) synthesis cost (small tripeptide synthesis is relatively economical), (2) copper-binding chemistry (the Cu(II) complex requires specific manufacturing controls), (3) analytical depth (HPLC, mass spec, ICP-MS testing adds cost), (4) batch volume (larger volumes reduce per-vial cost), and (5) supplier quality positioning (full-documentation suppliers price above minimal-documentation suppliers).

Is cheaper GHK-Cu always lower quality?

Not necessarily, but very low pricing is a yellow flag. Research-grade GHK-Cu under approximately $20 for a 50mg vial often comes with reduced analytical documentation, missing copper content verification, or generic non-batch-specific COAs. Quality is determined by the analytical specifications, so always compare price against documentation rather than against price alone.

Glossary

Key terms used in this article.

Lyophilized Peptide: Freeze-dried peptide in solid form, the preferred storage state for long-term research peptide stability.
ICP-MS Copper Quantification: The analytical procedure using inductively coupled plasma mass spectrometry to quantify the copper content in GHK-Cu, confirming the copper-to-peptide stoichiometry.
Synthesis Cost: The manufacturing cost of producing a peptide via solid-phase synthesis, varying by peptide length and chemical complexity.
Volume Pricing: Reduced per-unit pricing offered for bulk or recurring orders, typical in research peptide markets.
Analytical Depth: The breadth of analytical testing applied to a research peptide batch, including HPLC, mass spectrometry, ICP-MS, and endotoxin testing.
Batch Availability: The current inventory and turnover rate for a specific research peptide, affecting pricing dynamics in the supplier market.
Quality Positioning: A supplier's strategic choice between offering minimal documentation at lower prices versus full analytical documentation at higher prices.

More from the Blog

Continue exploring research insights and updates.

Tesofensine Appetite and Metabolic Research: Animal Model Studies

A research review of tesofensine appetite and metabolic studies covering central energy-balance circuits, food-intake endpoints, and rodent model literature. For research use only.

June 16, 2026

Tesofensine and Monoamine Reuptake: Dopamine, Norepinephrine, and Serotonin Research

A research review of tesofensine triple monoamine reuptake inhibition covering the dopamine, norepinephrine, and serotonin transporters and synaptic monoamine signaling in preclinical models. For research use only.

June 16, 2026

This is a research-context article. All discussion is framed around laboratory and in-vitro use. Nothing here describes or recommends therapeutic or personal use of GHK-Cu in humans or animals.

Typical 2026 Pricing for Research-Grade GHK-Cu

Research-grade GHK-Cu in 2026 typically prices in the following ranges:

50mg lyophilized vial: $30 to $80 from reputable RUO suppliers with full analytical documentation. Lower-end pricing usually means reduced analytical depth or generic COAs; higher-end pricing usually reflects full HPLC + mass spec + ICP-MS documentation and longer-established suppliers with consistent batch quality.
GHK-Cu capsules for oral research applications: typically $80 to $150 depending on capsule count and supplier. The capsule format adds manufacturing complexity beyond the lyophilized vial.
Multi-peptide blends containing GHK-Cu: GLOW 70mg (containing GHK-Cu, BPC-157, and TB-500) and KLOW 90mg (adding KPV to that combination) price higher than standalone GHK-Cu, reflecting the combined material costs.

These price ranges describe research-grade material with batch-specific Certificates of Analysis. Cosmetic OTC GHK-Cu products in retail skincare price differently because they are formulated as cosmetic products with low active ingredient concentrations and different regulatory framework. Cosmetic GHK-Cu products are not interchangeable with research-grade material; for the regulatory distinction, see Can You Buy GHK-Cu Over the Counter?.

What Drives GHK-Cu Pricing

Five factors interact to determine research-grade GHK-Cu pricing:

Synthesis cost. The GHK tripeptide is small (three amino acids) and the synthesis chemistry is well-characterized. Small peptide synthesis is relatively economical compared to larger peptides like the 39-amino-acid retatrutide (GLP-3 RT) or tirzepatide (GLP-2 TZ). This is why GHK-Cu is among the more accessibly priced research peptides.

Copper-binding chemistry. GHK-Cu requires the GHK peptide to be complexed with a Cu(II) ion under controlled chemistry. The copper-binding step adds manufacturing complexity beyond what a non-metal-bound peptide would require, and the stoichiometry (typically 1:1 copper-to-peptide) needs verification on every batch.

Analytical depth. Supplier costs scale with the analytical testing applied to each batch. HPLC purity verification (the minimum standard) is relatively inexpensive. Adding mass spectrometry identity confirmation increases cost. Adding ICP-MS copper quantification (the gold-standard test for confirming copper content) increases cost further. Suppliers that include all three on every batch price above suppliers that include only HPLC.

Batch volume. Research peptide manufacturing has economies of scale. Suppliers moving large batch volumes can reduce per-vial cost. Niche suppliers with low batch turnover often price higher per vial because their fixed costs spread across fewer units.

Quality positioning. Reliable suppliers with transparent analytical practices and strong third-party review profiles price above suppliers that compete primarily on price. The quality positioning reflects the overall operational depth (response time, customer support, batch consistency) that surrounds the analytical specifications.

For the integrated supplier evaluation framework, see the Most Reliable Peptide Company sourcing guide.

Why the Cheapest GHK-Cu Is Often a Yellow Flag

When researchers see GHK-Cu priced significantly below the typical $30 to $80 range for 50mg vials, several quality concerns are common:

Generic non-batch-specific COAs. Some suppliers ship GHK-Cu with generic supplier-wide COAs that do not match a specific lot number. These are insufficient for research reproducibility because batch-to-batch variation cannot be tracked.

Missing ICP-MS copper verification. ICP-MS quantification of the copper content is the gold-standard test for confirming the copper-to-peptide stoichiometry in GHK-Cu. Some lower-priced suppliers omit this test, which means the copper component of the molecule is unverified. Without ICP-MS, a researcher cannot be confident that the material received is the proper copper complex rather than the free GHK peptide or an off-stoichiometry mixture.

Reduced HPLC purity threshold. Some suppliers ship GHK-Cu with HPLC purity below the 98 percent research-grade standard. Reduced purity means more impurities, which can produce off-target effects in cellular and animal model research and confound mechanism studies.

Missing endotoxin testing. For in-vivo research applications, endotoxin testing under 5 EU/mg is the standard expectation. Lower-priced suppliers often omit this testing, which limits the material's research applicability.

Inconsistent batch quality. Suppliers competing on price often achieve that price by accepting more batch-to-batch variability, which compromises long-term research projects that require consistent quality across multiple orders.

The pattern is that very low pricing typically comes with reduced documentation, and the reduced documentation translates to reduced research utility. Comparing price against the analytical specifications on the COA is the right way to evaluate value, not comparing price alone.

How GHK-Cu Pricing Compares Across the Catalog

Research peptide pricing varies substantially across the catalog because synthesis complexity and analytical requirements differ. For context:

Bacteriostatic Water 30ml: $5 to $15. Simple chemistry, minimal analytical requirements.
Selank 10mg, Semax 10mg, MOTS-C 10mg: $30 to $60. Small to medium peptides with standard analytical requirements.
GHK-Cu 50mg: $30 to $80. Small peptide with copper-complexation chemistry adding modest cost.
BPC-157 10mg, TB-500 10mg: $40 to $80. Medium-length peptides.
GLP-1 SM (Semaglutide) 20mg: $80 to $200. Long-acting modified peptide with C18 diacid acylation.
GLP-2 TZ (Tirzepatide), GLP-3 RT (Retatrutide): $200 to $500 per vial. Long-acting modified 39-amino-acid peptides with C20 diacid acylation, the most expensive research peptides in the catalog due to synthesis complexity.

GHK-Cu's relatively accessible pricing reflects its small size and well-characterized chemistry, which makes it a practical research tool for labs working on dermal, copper peptide, and tissue regeneration research without the budget impact of the long-acting incretin agonist class.

Pricing for Research Designs That Use GHK-Cu Across Multiple Arms

Research labs running studies that use GHK-Cu in multiple experimental arms or across long timelines should plan pricing around several considerations:

Bulk and volume pricing. Many suppliers offer reduced per-unit pricing for orders of multiple vials or for recurring purchases. For long-term studies, establishing a recurring purchase relationship can reduce per-vial cost while maintaining batch consistency.

Multi-peptide blend economics. For research designs that use GHK-Cu in combination with BPC-157 and TB-500 (the GLOW configuration) or with KPV in addition (the KLOW configuration), the GLOW 70mg and KLOW 90mg blends can be more economical than purchasing the constituent peptides separately when the combination is the research focus.

Comparative research with other peptides. Labs running comparative arms that combine GHK-Cu with other peptides (BPC-157 10mg, TB-500 10mg, KPV where available) benefit from sourcing all materials from a single supplier with consistent analytical specifications. This reduces variability that would otherwise be introduced by multi-vendor sourcing.

Storage and reconstitution practicality. GHK-Cu is supplied lyophilized for storage stability. After reconstitution in bacteriostatic water, the material is stable for 28 to 30 days under refrigeration. Planning research timelines against the reconstituted stability window prevents unnecessary repeat purchases.

How to Compare One Supplier's GHK-Cu Pricing Against Another's

When evaluating GHK-Cu pricing across suppliers, the comparison framework should include:

Vial size and concentration. Compare equivalent-mass material. A 50mg vial at $50 is different from a 30mg vial at $30 on a per-mg basis.
HPLC purity. A vial documented at 99 percent HPLC purity is different from a vial documented at 95 percent purity on a research-utility basis.
Mass spec identity confirmation. Vials with mass spec confirming the GHK + Cu(II) molecular weight are different from vials without that confirmation.
ICP-MS copper quantification. Vials with ICP-MS confirming the copper content are different from vials without that quantification.
Batch-specific COA. Vials with COAs tied to the specific lot number are different from vials with generic supplier-wide COAs.
Endotoxin testing. Vials with endotoxin testing for in-vivo applications are different from vials without that testing.
Shipping and operational reliability. Same-day fulfillment and reliable transit times are part of the value, especially for time-sensitive research.

A vial that costs more but includes all seven dimensions can be a better value than a vial that costs less but is missing several. Headline pricing alone is not the right comparison metric.

What Midwest Peptide GHK-Cu Pricing Includes

Every GHK-Cu 50mg order from Midwest Peptide ships with:

Batch-specific Certificate of Analysis documenting lot number, HPLC purity, mass spectrometry molecular weight, ICP-MS copper quantification, peptide content, and synthesis date.
Lyophilized 50mg vial in insulated packaging engineered for peptide transit.
Same-business-day order processing for orders placed by 2 PM Central, with free domestic shipping.
Direct customer support for questions about COA details, batch availability, or analytical results.
Multiple secure payment options.
Full RUO disclaimer language on the product page, packaging, and order confirmation.

For the broader sourcing framework that applies to evaluating any GHK-Cu supplier, see the Where to Buy GHK-Cu for Research: Copper Peptide Sourcing Guide.

External References for GHK-Cu Pricing Context

For external context on the GHK-Cu market and broader research peptide pricing landscape:

The Wikipedia entry on GHK-Cu provides accessible coverage of the molecule and its applications.
Peer-reviewed primary research is at the Journal of Biological Chemistry for foundational papers.
Methodological references on copper peptide chemistry are at ScienceDirect for analytical and synthesis literature.
General research peptide market context is covered in industry publications and at American Chemical Society journals.

Bottom Line

Research-grade GHK-Cu in 2026 typically prices in the $30 to $80 range for a 50mg lyophilized vial from suppliers with full analytical documentation. Pricing reflects synthesis cost, copper-binding chemistry, analytical depth, batch volume, and supplier quality positioning. The cheapest material is often missing critical documentation (ICP-MS copper verification, batch-specific COAs, endotoxin testing) that affects research reproducibility. Comparing price against the analytical specifications on the COA is the right approach to evaluating value.

For research-grade GHK-Cu with full analytical documentation, see the GHK-Cu 50mg product page and the broader Midwest Peptide research catalog. All products are supplied strictly for laboratory and in-vitro research use only. Not for human consumption.

Within the cluster:

Age Verification

How Expensive Is GHK-Cu? (2026 Research Pricing Guide)